Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$2.8 - $3.96 $699,843 - $989,778
-249,944 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$3.63 - $6.13 $21,155 - $35,725
5,828 Added 2.39%
249,944 $980,000
Q3 2021

Nov 12, 2021

BUY
$5.5 - $7.41 $1.28 Million - $1.73 Million
233,251 Added 2146.81%
244,116 $1.61 Million
Q2 2021

Aug 12, 2021

SELL
$4.35 - $6.35 $603,127 - $880,427
-138,650 Reduced 92.73%
10,865 $67,000
Q1 2021

May 13, 2021

SELL
$3.94 - $7.09 $566,343 - $1.02 Million
-143,742 Reduced 49.02%
149,515 $676,000
Q4 2020

Feb 16, 2021

BUY
$5.45 - $8.65 $24,067 - $38,198
4,416 Added 1.53%
293,257 $1.76 Million
Q3 2020

Nov 12, 2020

BUY
$4.34 - $11.43 $723,551 - $1.91 Million
166,717 Added 136.51%
288,841 $2.15 Million
Q2 2020

Aug 13, 2020

SELL
$1.85 - $5.29 $57,873 - $165,487
-31,283 Reduced 20.39%
122,124 $490,000
Q1 2020

May 13, 2020

BUY
$1.24 - $4.35 $190,224 - $667,320
153,407 New
153,407 $389,000
Q3 2019

Nov 13, 2019

SELL
$4.63 - $12.15 $292,620 - $767,892
-63,201 Closed
0 $0
Q2 2019

Aug 07, 2019

SELL
$11.49 - $14.17 $298,222 - $367,782
-25,955 Reduced 29.11%
63,201 $779,000
Q1 2019

May 08, 2019

BUY
$8.47 - $14.36 $10,367 - $17,576
1,224 Added 1.39%
89,156 $1.19 Million
Q4 2018

Feb 12, 2019

SELL
$7.18 - $8.83 $661,278 - $813,243
-92,100 Reduced 51.16%
87,932 $758,000
Q3 2018

Nov 13, 2018

SELL
$5.92 - $8.35 $12,212 - $17,226
-2,063 Reduced 1.13%
180,032 $1.35 Million
Q2 2018

Aug 02, 2018

SELL
$4.86 - $6.24 $32,562 - $41,808
-6,700 Reduced 3.55%
182,095 $1.09 Million
Q1 2018

May 14, 2018

BUY
$5.75 - $7.97 $252,712 - $350,281
43,950 Added 30.34%
188,795 $1.1 Million
Q4 2017

Feb 09, 2018

BUY
$4.46 - $6.45 $153,954 - $222,647
34,519 Added 31.29%
144,845 $853,000
Q3 2017

Nov 14, 2017

BUY
$3.55 - $5.49 $132,063 - $204,233
37,201 Added 50.87%
110,326 $556,000
Q2 2017

Aug 14, 2017

BUY
N/A
73,125
73,125 $295,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $151M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.